Concepedia
Statistics
Publications
92
Citations
5.4K
H-Index
32
Active since
2006
Affiliations
Sanofi (United States)(Current)
University of California, Irvine
IQVIA (United States)
Ochsner Medical Center
Pfizer (United States)
Jay Lin is an author at Sanofi (United States) specializing in medicine, public health, and outcomes research.
Top concepts
MedicinePublic HealthOutcomes ResearchPatient SafetyThrombosisHealth PolicyHealth EconomicsEmergency MedicineCardiovascular DiseaseHealth Services Research
Publications per year
2006–2021
Increasing Prevalence of Atrial Fibrillation and Flutter in the United States
Gerald V. Naccarelli, Helen Varker, Jay Lin et al. · The American Journal of Cardiology · 2009 · 859 citations
Electrophysiological Evaluation, Cardiovascular Disease, Medicine +8
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United States
Alok A. Khorana, Mehul Dalal, Jay Lin et al. · Cancer · 2012 · 478 citations
Direct Medical Costs of Venous Thromboembolism and Subsequent Hospital Readmission Rates: An Administrative Claims Analysis From 30 Managed Care Organizations
Alex C. Spyropoulos, Jay Lin · Journal of Managed Care Pharmacy · 2007 · 331 citations · Full text
Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome
D. MacDougall, Anthony L. Feliu, Stephen J. Boccuzzi et al. · American Journal of Health-System Pharmacy · 2006 · 300 citations
Prevalence of clinical venous thromboembolism in the USA: Current trends and future projections
Steven Deitelzweig, Barbara H. Johnson, Jay Lin et al. · American Journal of Hematology · 2010 · 245 citations
U.s. Prevalence, Logistic Analysis, Thrombosis +20
1–5 of 92